GleamWall
中文EN

MIST Milestone Pharmaceuticals Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1408443 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-68.7%
TTM EPS YoY6.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-1,370.6%
ROA-78.2%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets103.8%
Debt / equity—
Current ratio6.27x
Interest coverage-7.62x

Cash quality & payout

Operating cash flow / net income0.78x
Accruals ratio-16.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$18.11M$14.36M
SG&A expense$17.27M$16.74M
Operating income-$62.14M-$42.10M
Interest expense$3.84M$3.58M
Pretax income-$63.06M-$41.52M
Net income-$63.06M-$41.52M
EBITDA-$62.03M-$42.00M
EPS (basic)-0.75-0.67
EPS (diluted)-0.75-0.67
Balance sheet
Cash & equivalents$73.05M$25.31M
Short-term investments$32.91M$44.38M
Inventory$648,000—
Current assets$111.92M$73.93M
PP&E, net$511,000$197,000
Total assets$113.56M$75.50M
Current liabilities$13.98M$8.13M
Long-term debt$57.19M$53.35M
Total debt$57.19M$53.35M
Total liabilities$71.79M$62.35M
Shareholders' equity$41.77M$13.15M
Net debt-$15.86M$28.04M
Shares outstanding106.24M53.35M
Cash flow statement
Operating cash flow-$49.04M-$28.85M
Capital expenditure$302,000$33,000
Free cash flow-$49.34M-$28.88M
Investing cash flow$11.25M$8.28M
Financing cash flow$85.53M$32.12M
Depreciation & amortization$114,000$105,000
Stock-based compensation$7.46M$5.78M

Free plan shows the latest 2 periods; Pro shows all 8 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.